Canada markets open in 7 hours 32 minutes

Daewoong Pharmaceutical Co., Ltd (069620.KS)

KSE - KSE Delayed Price. Currency in KRW
Add to watchlist
111,900.00-800.00 (-0.71%)
As of 02:38PM KST. Market open.
Currency in KRW

Valuation Measures4

Market Cap (intraday) 1.30T
Enterprise Value 1.60T
Trailing P/E 10.58
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.94
Price/Book (mrq)1.69
Enterprise Value/Revenue 1.16
Enterprise Value/EBITDA 8.92

Trading Information

Stock Price History

Beta (5Y Monthly) 0.89
52-Week Change 30.99%
S&P500 52-Week Change 325.59%
52 Week High 3127,600.00
52 Week Low 388,300.00
50-Day Moving Average 3115,572.00
200-Day Moving Average 3110,705.00

Share Statistics

Avg Vol (3 month) 326.94k
Avg Vol (10 day) 317.14k
Shares Outstanding 511.51M
Implied Shares Outstanding 611.53M
Float 85.36M
% Held by Insiders 161.70%
% Held by Institutions 113.70%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4600
Forward Annual Dividend Yield 40.52%
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 40.45
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Dec 28, 2022
Last Split Factor 21.03:1
Last Split Date 3Dec 27, 2012

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 8.85%
Operating Margin (ttm)7.52%

Management Effectiveness

Return on Assets (ttm)4.54%
Return on Equity (ttm)14.52%

Income Statement

Revenue (ttm)1.38T
Revenue Per Share (ttm)120,385.58
Quarterly Revenue Growth (yoy)10.40%
Gross Profit (ttm)N/A
EBITDA 164.91B
Net Income Avi to Common (ttm)121.74B
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)137.68B
Total Cash Per Share (mrq)11,966.08
Total Debt (mrq)441.27B
Total Debt/Equity (mrq)48.37%
Current Ratio (mrq)0.86
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)136.01B
Levered Free Cash Flow (ttm)-18.39B